Literature DB >> 25818902

Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .

Hiroki Shiomi1, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Ryuzo Sakata, Hitoshi Okabayashi, Michiya Hanyu, Mitsuomi Shimamoto, Noboru Nishiwaki, Tatsuhiko Komiya, Takeshi Kimura.   

Abstract

BACKGROUND: Studies evaluating long-term (≥5 years) outcome of percutaneous coronary intervention (PCI) compared with coronary artery bypass grafting (CABG) in patients with unprotected left main coronary artery disease (ULMCAD) are still limited, despite concerns for late adverse events after drug-eluting stents implantation. METHODS AND
RESULTS: We identified 1,004 patients with ULMCAD (PCI: n=364, CABG: n=640) among 15,939 patients with first coronary revascularization enrolled in the CREDO-Kyoto PCI/CABG registry cohort-2. The primary outcome measure in the current analysis was a composite of death, myocardial infarction, and stroke (death/MI/stroke). The cumulative 5-year incidence of and the adjusted risk for death/MI/stroke were significantly higher in the PCI group than in the CABG group (34.5% vs. 24.1%, log-rank P<0.001, adjusted hazard ratio (HR): 1.48 [95% confidence interval (CI): 1.07-2.05, P=0.02]). The adjusted risks for all-cause death was not significantly different between the 2 groups. Regarding the stratified analysis by the SYNTAX score, the adjusted risk for death/MI/stroke was not significantly different between the 2 groups in patients with low (<23) or intermediate (23-33) SYNTAX score, whereas it was significantly higher in the PCI group than in the CABG group in patients with high (≤33) SYNTAX score.
CONCLUSIONS: CABG as compared with PCI was associated with better long-term outcome in patients with ULMCAD, especially those with high anatomical complexity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25818902     DOI: 10.1253/circj.CJ-15-0034

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  9 in total

1.  "You don't need a weather man to know which way the wind blows": understanding differences and applications in clinical practice of randomized controlled trials on unprotected left main.

Authors:  Fabrizio D'Ascenzo; Ovidio De Filippo; Maurizio Bertaina; Mario Iannaccone; Fiorenzo Gaita
Journal:  Ann Transl Med       Date:  2017-02

2.  Percutaneous coronary intervention versus bypass grafting in left main coronary artery disease.

Authors:  Stine Munkholm-Larsen; Tristan D Yan
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease: A systematic review & meta-analysis.

Authors:  Talal Almas; Ahson Afzal; Hameeda Fatima; Sadia Yaqoob; Furqan Ahmad Jarullah; Zaeem Ahmed Abbasi; Anoosh Farooqui; Duaa Jaffar; Atiya Batool; Shayan Ahmed; Neha Sara Azmat; Fatima Afzal; Sarah Zafar Khan; Kaneez Fatima
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-25

4.  Meta-analysis study comparing percutaneous coronary intervention/drug eluting stent versus coronary artery bypass surgery of unprotected left main coronary artery disease: Clinical outcomes during short-term versus long-term (> 1 year) follow-up.

Authors:  Waleed E Ali; Satyanarayana R Vaidya; Sylvester U Ejeh; Kingsley U Okoroafor
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

Review 5.  Percutaneous Coronary Intervention, Coronary Artery Bypass Surgery and the SYNTAX score: A systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Chandra Mouli Yanamala; Feng Huang
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

6.  Procedural Volume and Outcomes After Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease-Report From the National Clinical Data (J-PCI Registry).

Authors:  Tadao Aikawa; Kyohei Yamaji; Toshiyuki Nagai; Shun Kohsaka; Kiwamu Kamiya; Kazunori Omote; Taku Inohara; Yohei Numasawa; Kenichi Tsujita; Tetsuya Amano; Yuji Ikari; Toshihisa Anzai
Journal:  J Am Heart Assoc       Date:  2020-04-29       Impact factor: 5.501

7.  Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.

Authors:  Xia Han; Lili Liu; Jiamin Niu; Jun Yang; Zengtang Zhang; Zhiqiang Zhang
Journal:  Med Sci Monit       Date:  2015-10-26

8.  Percutaneous coronary intervention versus cardiac bypass surgery for left main coronary artery disease: A trial sequential analysis.

Authors:  Yicong Ye; Ming Yang; Shuyang Zhang; Yong Zeng
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

Review 9.  Worse clinical outcomes following percutaneous coronary intervention with a high SYNTAX score: A systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Akash Bhurtu; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.